STOCKSWhy Investors Should Favor Smaller Biotech CompaniesBy Alexander NicollOct 24, 2018 11:04 PM EDT
STOCKSAdamis Pharma Shares Soar on Deal With Novartis for Epipen CompetitorBy Alexander NicollJul 2, 2018 11:04 AM EDT
HEALTHBiotech Movers: Adamis Shares Jump After FDA Approval For Epinephrine Pre-filled SyringeBy Armie Margaret LeeJun 16, 2017 9:52 AM EDT
STOCKSThese 5 stocks under $10 could make you a lot of moneyBy Roberto PedoneDec 22, 2016 1:10 PM EST
INVESTINGEpiPen price relief could come from rivals before politiciansBy Anders KeitzSep 2, 2016 5:10 PM EDT
MARKETSHere's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Slumping TodayBy Rachel AldrichAug 29, 2016 3:49 PM EDT
STOCKSPharma has history of price gouging, mylan should be no surpriseBy Alicia McElhaneyAug 26, 2016 4:33 PM EDT
STOCKSHere's who shouldn't fret the initial fallout from Mylan fiascoBy Alicia McElhaneyAug 26, 2016 2:01 PM EDT
MARKETSHere's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Soaring TodayBy Rachel AldrichAug 26, 2016 11:36 AM EDT
STOCKSMylan is done leaning on EpiPen sales and that could be a big problemBy Alicia McElhaneyAug 25, 2016 11:07 AM EDT
STOCKSA backlash materializes against soaring EpiPen pricesBy Alicia McElhaneyAug 23, 2016 12:02 PM EDT
MARKETSAdamis Pharmaceuticals (ADMP) Stock Plummeting on FDA Drug RejectionBy Amanda SchiavoJun 6, 2016 10:19 AM EDT
